Upstream Biosciences

Upstream Biosciences was a Canadian biotechnology company focused on the discovery and development of novel therapeutics and diagnostics for tropical and infectious diseases. The company utilized a proprietary bioinformatics platform to identify genetic variations and target enzymes, such as trypanothione reductase, which are essential for the survival of parasites causing diseases like leishmaniasis and African sleeping sickness. Founded by the creators of DoubleTwist, Upstream Biosciences aimed to leverage genetic data to streamline drug discovery and predict patient response. Although the company was publicly traded on the OTCBB and advanced several small molecule candidates through early pre-clinical stages, it ultimately ceased operations and is currently considered inactive.